330 results on '"Morgan, Jennifer E."'
Search Results
2. Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model
3. Engineered human myogenic cells in hydrogels generate functional myofibers within dystrophic mouse muscle
4. Myogenic Cell Proliferation and Generation of a Reversible Tumorigenic Phenotype Are Triggered by Preirradiation of the Recipient Site
5. Antisense-Induced Exon Skipping and Synthesis of Dystrophin in the mdx Mouse
6. Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell-like Properties as the Myogenic Source
7. Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models
8. Genome Editing and Muscle Stem Cells as a Therapeutic Tool for Muscular Dystrophies
9. Adult Stem Cells: Adult Skeletal Muscle Stem Cells
10. Satellite cells from dystrophic muscle retain regenerative capacity
11. Publisher Correction: Necroptosis mediates myofibre death in dystrophin-deficient mice
12. Necroptosis mediates myofibre death in dystrophin-deficient mice
13. 153 The engraftment, survival, and contribution of PW1-positive/Pax7-negative interstitial progenitor cells (PICs), a source of cellular regenerative therapy, in a mouse model of muscular dystrophy
14. Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
15. Lentiviral vectors can be used for full-length dystrophin gene therapy
16. Stem cells to treat muscular dystrophies – Where are we?
17. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
18. CRISPR-mediated correction of skeletal muscle Ca2+handling in a novel DMD patient-derived pluripotent stem cell model
19. Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy
20. Myoblast transplantation in inherited myopathies
21. Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials
22. Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials
23. The contribution of human synovial stem cells to skeletal muscle regeneration
24. Direct effects of the pathogenic mutation on satellite cell function in muscular dystrophy
25. Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles
26. Practical Aspects of Myoblast Implantation: Investigations on Two Inherited Myopathies in Animals
27. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
28. Normal Myogenic Cells from Newborn Mice Restore Normal Histology to Degenerating Muscles of the mdx Mouse
29. High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients
30. Dystrophin involvement in peripheral circadian SRF signalling
31. CORRESPONDENCE: Measuring dystrophin—faster is not necessarily better
32. Dystrophin regulates peripheral circadian SRF signalling
33. Adult Stem Cells: Adult Skeletal Muscle Stem Cells
34. The altered expression of neurofilament in mouse models and patients with spinal muscular atrophy
35. Modulation of the Host Skeletal Muscle Niche for Donor Satellite Cell Grafting
36. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche
37. Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements
38. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover
39. Recent progress in satellite cell/myoblast engraftment – relevance for therapy
40. The human desmin locus: Gene organization and LCR-mediated transcriptional control
41. Potentiation of myoblast transplantation by host muscle irradiation is dependent on the rate of radiation delivery
42. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
43. Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
44. Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
45. Dual regulation of the AMP‐activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle
46. MYOBLAST THERAPY
47. CONTRIBUTORS
48. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration
49. Release of reactive oxygen and nitrogen species from contracting skeletal muscle cells
50. Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.